Elvitegravir (GS-9137,JTK 303)
Inquiry
Post Date: | Apr 03,2015 |
Expiry Date: | Apr 02,2016 |
Detailed Description: |
Cas No. :697761-98-1
Quantity: 50g Specs:98% purity Payment Method: T/T, Western Union Elvitegravir (EVG) is an investigational new drug for the treatment of HIV infection. It acts as an integrase inhibitor. It is undergoing a Phase III clinical trial. According to the results of the phase II clinical trial, patients taking once-daily elvitegravir boosted by ritonavir had greater reductions in viral load after 24 weeks compared to individuals randomized to receive a ritonavir-boosted protease inhibitor. |
CAS Registry Number: | 697761-98-1 |
Synonyms: | ;GS-9137;JTK-303;6-(3-chloro-2-fluorobenzyl)-1-[1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;(S)-6-(3-Chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;6-(3-Chloro-2-fluorobenzyl)-1-[1(S)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; |
Molecular Formula: | C23H23ClFNO5 |
Molecular Weight: | 447.8838 |
Molecular Structure: |
Company: | Shanghai Sun-shineChemical Technology Co.,Ltd. [ China ] |
Contact: | Rosie |
Tel: | +86-027-59253327 |
Fax: | 0086-27-5925 3326 |
Email: | sales02@sun-shinechem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.